LadRx Corp (LADX) Financial Statements (2026 and earlier)

Company Profile

Business Address 11726 SAN VICENTE BOULEVARD
LOS ANGELES, CA 90049
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments759,7422,070,0751,374,9926,769,60310,003,37516,130,410
Cash and cash equivalent759,7422,070,0751,374,9926,769,60310,003,37516,130,410
Other undisclosed cash, cash equivalents, and short-term investments      
Receivables    200,000325,1057,628
Other undisclosed current assets77,296191,783628,7451,310,3821,094,6751,066,497
Total current assets:837,0382,261,8582,003,7378,279,98511,423,15517,204,535
Noncurrent Assets
Operating lease, right-of-use asset  31,610216,786397,172580,478 
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization9996,71118,54632,78439,75842,893
Other noncurrent assets1,4757,7037,70316,83616,8367,590
Total noncurrent assets:2,47446,024243,035446,792637,07250,483
TOTAL ASSETS:839,5122,307,8822,246,7728,726,77712,060,22717,255,018
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,258,9412,166,9221,941,2542,663,7902,583,6682,040,835
Employee-related liabilities261,375215,191268,000
Accounts payable1,056,6621,202,689975,9441,470,6521,402,054887,835
Accrued liabilities 1,202,279964,233965,310931,763966,423885,000
Other undisclosed current liabilities 33,606246,2721,070,187190,3999,471
Total current liabilities:2,258,9412,200,5282,187,5263,733,9772,774,0672,050,306
Noncurrent Liabilities
Long-term debt and lease obligation:    216,381415,200 
Liabilities, other than long-term debt   33,526   
Operating lease, liability   33,526216,381415,200 
Other undisclosed noncurrent liabilities    (216,381)(415,200) 
Total noncurrent liabilities:   33,526216,381415,200 
Total liabilities:2,258,9412,200,5282,221,0523,950,3583,189,2672,050,306
Temporary equity, including noncontrolling interest   1,343,6844,022,700  
Equity
Equity, attributable to parent(1,419,429)107,354(1,317,964)753,7198,870,96015,204,712
Common stock49549545,03738,78036,48033,637
Additional paid in capital488,675,792488,612,890487,474,664484,790,650479,561,860479,197,849
Accumulated deficit(490,095,716)(488,506,031)(488,837,665)(484,075,711)(470,727,380)(464,026,774)
Total equity:(1,419,429)107,354(1,317,964)753,7198,870,96015,204,712
TOTAL LIABILITIES AND EQUITY:839,5122,307,8822,246,7728,726,77712,060,22717,255,018

Income Statement (P&L) (USD)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Gross profit: (30,000)     
Operating expenses(3,623,142)(3,823,626)(4,560,888)(12,076,990)(6,829,151)(7,861,474)
Other undisclosed operating income 30,000     
Operating loss:(3,623,142)(3,823,626)(4,560,888)(12,076,990)(6,829,151)(7,861,474)
Nonoperating income (expense)  1,416(2,615)(6,842)129,345339,452
Investment income, nonoperating     119,274351,968
Loss, foreign currency transaction, before tax   (2,889)(22,440)  
Loss from continuing operations before equity method investments, income taxes:(3,623,142)(3,822,210)(4,563,503)(12,083,832)(6,699,806)(7,522,022)
Other undisclosed loss from continuing operations before income taxes    (1,092,831)  
Loss from continuing operations before income taxes:(3,623,142)(3,822,210)(4,563,503)(13,176,663)(6,699,806)(7,522,022)
Income tax expense (benefit)     (800)800
Loss from continuing operations:(3,623,142)(3,822,210)(4,563,503)(13,176,663)(6,700,606)(7,521,222)
Loss before gain (loss) on sale of properties:(13,176,663)(6,700,606)(7,521,222)
Net loss:(3,623,142)(3,822,210)(4,563,503)(13,176,663)(6,700,606)(7,521,222)
Other undisclosed net income attributable to parent2,033,4574,222,653362,930  358,533
Net income (loss) attributable to parent:(1,589,685)400,443(4,200,573)(13,176,663)(6,700,606)(7,162,689)
Preferred stock dividends and other adjustments  (68,809)(561,381)(171,668)  
Net income (loss) available to common stockholders, diluted:(1,589,685)331,634(4,761,954)(13,348,331)(6,700,606)(7,162,689)

Comprehensive Income (USD)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(3,623,142)(3,822,210)(4,563,503)(13,176,663)(6,700,606)(7,521,222)
Comprehensive loss, net of tax, attributable to parent:(3,623,142)(3,822,210)(4,563,503)(13,176,663)(6,700,606)(7,521,222)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: